Clinicopathological analysis of 598 malignant lymphomas in Taiwan: seven-year experience in a single institution
- PMID: 16823825
- DOI: 10.1002/ajh.20649
Clinicopathological analysis of 598 malignant lymphomas in Taiwan: seven-year experience in a single institution
Abstract
The clinicopathological characteristics of malignant lymphomas vary according to geography. The purpose of this study is to determine the distribution and clinicopathological characteristics of malignant lymphomas in Taiwan. Archival tissue from 598 malignant lymphomas during the period of 1995-2002 was retrieved. They were reclassified according to the World Health Organization classification system. Clinical data, including age, gender, clinical staging, and follow-up, were scrutinized. There were 330 males and 268 females. The median age at onset of disease was 56 years for B-cell lymphoma (BCL), 50 years for T/NK-cell lymphoma (TCL), and 26 years for Hodgkin's lymphoma (HL). BCL accounted for 80.6%, TCL for 12.4%, and HL for 7%. The major subtypes of non-HL were diffuse large B-cell lymphoma, follicular lymphoma, plasma cell myeloma, marginal zone lymphoma of mucosa-associated lymphoid tissue type, mantle cell lymphoma, unspecified peripheral TCL, and nasal type T/NK-cell lymphoma. Nodular sclerosing subtype was the most common in HL. The frequencies of TCL and HL were relatively low. For histological subtype, enteropathy-type TCL and primary bone marrow HL had higher frequency and poorer prognosis. The 5-year overall survival of BCL, TCL, and HL was 58.9, 34.7, and 83.5%, respectively. To the best of our knowledge, this is the largest series study of malignant lymphoma in Taiwan. Immunophenotype, histological subtype, and clinical stage play significant roles in prognosis (P < 0.05).
Similar articles
-
Clinicopathological analysis of T-cell lymphoma in Taiwan according to WHO classification: high incidence of enteropathy-type intestinal T-cell lymphoma.Eur J Haematol. 2005 Sep;75(3):221-6. doi: 10.1111/j.1600-0609.2005.00495.x. Eur J Haematol. 2005. PMID: 16104878
-
REAL classification of malignant lymphomas in the Republic of Korea: incidence of recently recognized entities and changes in clinicopathologic features. Hematolymphoreticular Study Group of the Korean Society of Pathologists. Revised European-American lymphoma.Cancer. 1998 Aug 15;83(4):806-12. Cancer. 1998. PMID: 9708949
-
Malignant lymphoma in southern Taiwan according to the revised European-American classification of lymphoid neoplasms.Cancer. 2000 Oct 1;89(7):1586-92. Cancer. 2000. PMID: 11013375
-
[World Health Organization (WHO) classification of malignant lymphoma--how is the WHO now?].Gan To Kagaku Ryoho. 2004 Feb;31(2):149-57. Gan To Kagaku Ryoho. 2004. PMID: 14997743 Review. Japanese.
-
[Primary breast lymphoma--a report of 27 cases with literature review].Ai Zheng. 2007 Jan;26(1):84-9. Ai Zheng. 2007. PMID: 17222374 Review. Chinese.
Cited by
-
Treatment outcomes of and prognostic factors for definitive radiotherapy with and without chemotherapy for Stage I/II nasal extranodal NK/T-cell lymphoma.J Radiat Res. 2017 Jan;58(1):114-122. doi: 10.1093/jrr/rrw081. Epub 2016 Aug 16. J Radiat Res. 2017. PMID: 27534792 Free PMC article.
-
Mice hypomorphic for Atr have increased DNA damage and abnormal checkpoint response.Mamm Genome. 2009 Jun;20(6):375-85. doi: 10.1007/s00335-009-9195-4. Epub 2009 Jun 7. Mamm Genome. 2009. PMID: 19504344
-
How useful is bone marrow study as an initial investigative tool without lymph node biopsy in malignant lymphoma?: Eleven years of experience at a single institution.J Clin Lab Anal. 2019 May;33(4):e22841. doi: 10.1002/jcla.22841. Epub 2019 Feb 6. J Clin Lab Anal. 2019. PMID: 30724410 Free PMC article.
-
Aberrant antigenic expression in extranodal NK/T-cell lymphoma: a multi-parameter study from Thailand.Diagn Pathol. 2011 Aug 25;6:79. doi: 10.1186/1746-1596-6-79. Diagn Pathol. 2011. PMID: 21867533 Free PMC article.
-
Treatment of mantle cell lymphoma in Asia: a consensus paper from the Asian Lymphoma Study Group.J Hematol Oncol. 2020 Mar 17;13(1):21. doi: 10.1186/s13045-020-00855-9. J Hematol Oncol. 2020. PMID: 32183871 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical